Over the past 12 months, 0 insiders at TFF Pharmaceuticals, Inc. filed 0 open-market SEC Form 4 transactions on TFFP: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 16, 23 | Clint Duane CarlsonTenPercentOwner | SELL | 1.0K | $0.39 | $390 |
| Aug 15, 23 | Kirk Allen ColemanChief Financial Officer | BUY | 20.0K | $0.25 | $5K |
| Aug 15, 23 | Clint Duane CarlsonTenPercentOwner | SELL | 215.0K | $0.44 | $95K |
| Aug 15, 23 | Robert S MillsDirector | BUY | 40.0K | $0.25 | $10K |
| Aug 15, 23 | Zamaneh MikhakChief Medical Officer | BUY | 120.0K | $0.25 | $30K |
| Aug 15, 23 | Stephen RocamboliDirector | BUY | 20.0K | $0.25 | $5K |
| Aug 15, 23 | Brandi RobertsDirector | BUY | 20.0K | $0.25 | $5K |
| Aug 15, 23 | Harlan F WeismanPresident and CEO | BUY | 600.0K | $0.25 | $150K |
| Mar 10, 23 | Kirk Allen ColemanChief Financial Officer | BUY | 12.0K | $0.79 | $9K |
| Mar 10, 23 | Zamaneh MikhakChief Medical Officer | BUY | 15.0K | $0.82 | $12K |
| Mar 10, 23 | Stephen RocamboliDirector | BUY | 13.0K | $0.80 | $10K |
| Mar 10, 23 | Harlan F WeismanPresident and CEO | BUY | 150.0K | $0.88 | $132K |
| Dec 15, 22 | Harlan F WeismanPresident and CEO | BUY | 50.0K | $1.06 | $53K |
| Nov 22, 22 | Aaron G.l. FletcherDirector | BUY | 43.5K | $1.15 | $50K |
| Sep 29, 22 | Randy H ThurmanDirector | SELL | 40.3K | $4.29 | $173K |
| May 20, 22 | Harlan F WeismanDirector | BUY | 4.6K | $5.50 | $25K |
| May 18, 22 | Harlan F WeismanDirector | BUY | 2.5K | $5.12 | $13K |
| May 17, 22 | Kirk Allen ColemanChief Financial Officer | BUY | 425 | $4.83 | $2K |
| May 17, 22 | Aaron G.l. FletcherDirector | BUY | 24.6K | $5.08 | $125K |
| May 16, 22 | Kirk Allen ColemanChief Financial Officer | BUY | 1.3K | $4.40 | $6K |
| May 16, 22 | Aaron G.l. FletcherDirector | BUY | 85.0K | $4.86 | $413K |
| May 16, 22 | Glenn R. MattesPresident and CEO | BUY | 16.0K | $4.78 | $76K |
| May 16, 22 | Stephen RocamboliDirector | BUY | 3.0K | $4.54 | $14K |
| May 16, 22 | Harlan F WeismanDirector | BUY | 2.5K | $4.74 | $12K |
| Apr 4, 22 | Aaron G.l. FletcherDirector | BUY | 500.0K | $6.89 | $3.2M |
| Sep 16, 21 | Kirk Allen ColemanCFO, Secretary and Treasurer | BUY | 1.0K | $7.30 | $7K |
| Sep 16, 21 | Glenn R. MattesPresident and CEO | BUY | 10.0K | $7.10 | $71K |
Over the past 12 months, insiders at TFF Pharmaceuticals, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on TFFP, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market TFFP insider purchase in our data was $3.2M by Aaron G.l. Fletcher, Director, filed on Apr 4, 22.
0 different insiders at TFF Pharmaceuticals, Inc. filed open-market SEC Form 4 transactions on TFFP over the last 12 months.
InsiderTape plots every TFFP insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every TFF Pharmaceuticals, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →